KSHB: ‘Have Hope’: Study Shows Immunotherapy Continues To Change Future of Cancer Treatment

A new phase in a clinical trial for treating certain kinds of tumors with immunotherapy continues to pave the way for the future of treating patients with cancer.

Immunotherapy is making a big impact in the lives of patients like Michael Delaney, who battles a rare cancer known as thymic carcinoma and has received almost 200 rounds of immunotherapy.

KSHB talked with Dr. Marc Roth, Medical Director of Gastrointestinal Oncology at Saint Luke's, and Dr. Timothy Pluard, Medical Director at Saint Luke's Cancer Institute, about the latest research on immunotherapy and how it works.

Related Content

Thumbnail
Jul. 2, 2019

KCTV: Immunotherapy Treatment Offers New Hope to Dying Man

For many, the first thing that comes to mind for cancer treatment is chemotherapy. But Saint Luke's offers an innovative, alternative treatment for cancer patients that can add years to their lives.
Thumbnail
Apr. 24, 2019

KSHB: Immunotherapy Helps Local Woman Beat Uncommon Form of Cancer
After being diagnosed with an extremely rare and deadly form of blood cancer, a Kansas City woman is now beating the odds with the help of immunotherapy.
Mar. 11, 2025

KSHB: New Cancer Treatment at Saint Luke’s Extends Kansas Woman’s Life Expectancy
Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.